The expression patterns of CD44, HAS1 and MMP9 in ccRCC-TT exhibited a similar expression tendency, indicating that the CD44/HAS1/MMP9 regulatory system may have a significant impact on the aggressiveness of ccRCC. This evidence concerns the gene HAS1 and nonpapillary renal cell carcinoma.